Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06336135
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-03-28
First Post:
2024-03-22
Brief Title:
Reduction in Symptoms After Laser Therapy With Acorn aHFS
Sponsor:
Acorn Biolabs Inc
Organization:
Acorn Biolabs Inc
Study Overview
Official Title:
A Prospective Single-blind Randomized Placebo-controlled Clinical Trial Evaluating Reduction in Severity and Duration of Symptoms After Laser Therapy With Acorn aHFS
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the severity and duration of symptoms experienced after laser therapy comparing four post-procedure topical products Each product is applied to an individual region of interest 5 cm diameter on the back or décolleté according to randomization code after laser therapy The subject blind to the product applied to each of 4 regions of interest assesses eight symptoms daily for 14 days Photography is performed daily
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None